Package 0276-0500-10

Brand: chlordiazepoxide hydrochloride and clidinium bromide

Generic: chlordiazepoxide hydrochloride, clidinium bromide
NDC Package

Package Facts

Identity

Package NDC 0276-0500-10
Digits Only 0276050010
Product NDC 0276-0500
Description

100 CAPSULE in 1 BOTTLE (0276-0500-10)

Marketing

Marketing Status
Marketed Since 2020-09-03
Brand chlordiazepoxide hydrochloride and clidinium bromide
Generic chlordiazepoxide hydrochloride, clidinium bromide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4139e8c6-5256-6934-e063-6294a90aa5a0", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["a42fc981-77bc-4c9e-a79d-b821bffb65b4"], "manufacturer_name": ["Misemer Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0276-0500-10)", "package_ndc": "0276-0500-10", "marketing_start_date": "20200903"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "0276-0500_4139e8c6-5256-6934-e063-6294a90aa5a0", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "0276-0500", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride, Clidinium Bromide", "labeler_name": "Misemer Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA210579", "marketing_category": "ANDA", "marketing_start_date": "20200903", "listing_expiration_date": "20261231"}